These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 7288588
1. [Teratogenicity of aminopyrine and its molecular compound with barbital]. Nomura T, Isa Y, Sakamoto Y. Yakugaku Zasshi; 1981 May; 101(5):470-6. PubMed ID: 7288588 [No Abstract] [Full Text] [Related]
2. [Enhancement effects of barbital and phenobarbital on aminopyrine-initiated teratogenesis in mice]. Isa Y, Nomura T. Yakugaku Zasshi; 1981 May; 101(5):477-81. PubMed ID: 7288589 [No Abstract] [Full Text] [Related]
4. The teratogenicity of barbital sodium in mice. Persaud TV, Henderson WM. Arzneimittelforschung; 1969 Aug; 19(8):1309-10. PubMed ID: 4897401 [No Abstract] [Full Text] [Related]
5. Central nervous system supersensitivity and withdrawal from long-term treatment with barbital. Sandoval MR, Palermo-Neto J. Neuropharmacology; 1985 Dec; 24(12):1247-51. PubMed ID: 4094660 [Abstract] [Full Text] [Related]
6. The effects of gold-containing compounds on pregnant rabbits and their fetuses. Szabo KT, DiFebbo ME, Phelan DG. Vet Pathol; 1978 Aug; 15 Suppl 5():97-102. PubMed ID: 153630 [No Abstract] [Full Text] [Related]
7. Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray-drying technique. Kawashima Y, Lin SY, Ueda M, Takenaka H, Ando Y. J Pharm Sci; 1983 May; 72(5):514-8. PubMed ID: 6864497 [Abstract] [Full Text] [Related]
9. [Fetal hydantoin syndrome]. Gómez Gómez M, Cruz Bolaños JA. Bol Med Hosp Infant Mex; 1981 Feb 02; 38(2):291-9. PubMed ID: 7259848 [Abstract] [Full Text] [Related]
10. [Considerations regarding the search for barbiturates in viscera]. VIGNOLI. Ann Med Leg Criminol Police Sci Toxicol; 1947 Feb 02; 5(5):200. PubMed ID: 18897925 [No Abstract] [Full Text] [Related]
12. [Picrotoxin, antidote to barbiturates]. KEIL C. Rev Med Liege; 1949 Oct 01; 4(19):585-8. PubMed ID: 18142034 [No Abstract] [Full Text] [Related]
13. Abortion, partial resorption & retardation of foetal growth in rats chronically treated with barbital sodium during pregnancy. Champakamalini AV, Appaswami Rao M. Indian J Exp Biol; 1977 May 01; 15(5):346-8. PubMed ID: 924524 [No Abstract] [Full Text] [Related]
14. The influence of single or fractionated doses of 5-fluoro-2'-deoxycytidine teratogenicity in mice. Sasaki H, Omori K. Teratology; 1973 Oct 01; 8(2):191-4. PubMed ID: 4746982 [No Abstract] [Full Text] [Related]
16. Characteristic biotransformation of aminopyrine in rat when administered with barbital. Matsuyama K, Kado K, Nishiuchi M, Goromaru T, Tsuzuki O, Noda A, Iguchi S. J Pharmacobiodyn; 1981 Jan 01; 4(1):28-34. PubMed ID: 7277190 [Abstract] [Full Text] [Related]
17. [Raman spectra and structure of molecular addition compound of aminopyrine and barbital in aqueous solution]. KASHIMA T, WATARI T, MIKUBO H. Eisei Shikenjo Hokoku; 1961 Sep 01; 79():59-63. PubMed ID: 14454136 [No Abstract] [Full Text] [Related]
18. Teratogenicity and lethality of hydantoin derivatives in the mouse: structure--toxicity relationships. Brown NA, Shull G, Kao J, Goulding EH, Fabro S. Toxicol Appl Pharmacol; 1982 Jun 30; 64(2):271-88. PubMed ID: 7123555 [No Abstract] [Full Text] [Related]
19. The use of submerged limb culture and image analysis for evaluating retinoic acid-induced dose-related effects. Skalko RG, Kwasigroch TE. Prog Clin Biol Res; 1985 Jun 30; 163C():115-20. PubMed ID: 3991612 [No Abstract] [Full Text] [Related]